Data Suggests COVID-19 Vaccine Candidate 90% Effective

According to a recent press release, Pfizer, Inc., in partnership with BioNtech, have announced that early data from their COVID-19 vaccine trial has demonstrated high effectiveness. The Phase 3 vaccine candidate’s early results found the immunization to be 90% effective in preventing COVID-19 in participants without prior evidence of the …